Tyrosine kinase inhibitors induced immune thrombocytopenia in chronic myeloid leukemia?

Tyrosine kinase inhibitors induced immune thrombocytopenia in chronic myeloid leukemia?

The outcome and quality of life of chronic myeloid leukemia (CML) patients has remarkably changed with the treatment of tyrosine kinase inhibitors (TKIs). Currently, hematopoietic stem cell transplantation (HSCT) is considered mainly as a third line salvage therapy in cases of TKIs resistance or int...

Full description

Bibliographic Details
Main Authors: Avital F. Barak, Lilach Bonstein, Roy Lauterbach, Elizabeth Naparstek, Sigal Tavor
Format: Article
Language:English
Published: PAGEPress Publications 2011-12-01
Series:Hematology Reports
Subjects:
chronic myeloid leukemia, tyrosine kinase inhibitor, thrombocytopenia, HSCT
Online Access:http://www.pagepress.org/journals/index.php/hr/article/view/3322

Similar Items

Similar Items